Related Experiment Video
Updated: Feb 8, 2026

Fabrication of Superhydrophobic Metal Surfaces for Anti-Icing Applications
Published on: August 15, 2018
Floatable superhydrophobic Ag2O photocatalyst without a modifier and its controllable wettability by particle size
Wei Jiang1, Hongyan Fu, Yingming Zhu
1Multi-Phase Mass Transfer and Reaction Engineering Laboratory, School of Chemical Engineering, Sichuan University, Chengdu, 610065, China. weijiang@scu.edu.cn.
Abstract:
In this research, a controlling mechanism of particle size on the wettability of Ag2O particles is reported, and an interesting floatable Ag2O photocatalyst with superhydrophobicity and superoleophilicity is prepared based on this mechanism. Stable superhydrophobic and superhydrophilic Ag2O without a low-surface-energy modifier can be obtained only by adjusting its particle size, and its wettability can switch mutually by changing the particle size. The wettability of Ag2O converts from superhydrophilic to hydrophobic when the average particle size is more than 1.08 μm. The operation parameters of the Ag2O crystallization process significantly influence the wettability of the Ag2O particles. The obtained superhydrophobic Ag2O floated on the water surface, and exhibited excellent photodegradation performance with various floating oils. This attractive superhydrophobic Ag2O photocatalyst is promising for practical applications, and provides a strategy for the development of functional photocatalysts and superhydrophobic materials.
Related Concept Videos
Precipitate Formation and Particle Size Control
The obtained precipitate should be either a pure substance of known composition or easily converted to one by a simple process, such as ignition or drying. In addition, the precipitate should be insoluble and easily filterable. In general, filterability...
Basic Postulates of Kinetic Molecular Theory: Particle Size, Energy, and Collision
Factors Affecting Dissolution: Particle Size and Effective Surface Area
The Anchoring-and-Adjustment Heuristic
Adjusting a Traverse
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

